193
Views
25
CrossRef citations to date
0
Altmetric
Original

Elevated creatine kinase and transaminases in asymptomatic SBMA

&
Pages 62-64 | Received 03 Mar 2006, Accepted 04 Apr 2006, Published online: 10 Jul 2009

References

  • La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H. Androgen receptor gene mutations in X‐linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77–9
  • Harding A. E., Thomas P. K., Baraitser M., Bradbury P. G., Morgan‐Hughes J. A., Ponsford J. R. X‐linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry 1982; 45: 1012–9
  • Kennedy W. R., Alter M., Sung J. H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex‐linked recessive trait. Neurology 1968; 18: 671–80
  • Sinnreich M., Sorenson E. J., Klein C. J. Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy. Canadian Journal of Neurological Sciences 2004; 31: 378–82
  • Abel A., Walcott J., Woods J., Duda J., Merry D. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Human Molecular Genetics 2001; 10: 107–16
  • Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002; 35: 843–54

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.